Molekularne aspekty nowotworzenia - wybrane zagadnienia

• Autorzy: Madej J A

Warianty tytułu

EN

Molecular aspects of neoplasia - selected problems

• Języki publikacji: PL

Abstrakty

EN

At the basis of neoplastic processes there lie molecular lesions i.e. non-lethal, multi-stage damage to genetic material. The paper describes damage to nuclear chromatin and the role of RNA in neoplasia as well as the involvement of adhesion molecules, extracellular matrix (ECM), signal transduction (including humoral signals) and the role of cell cycle in the process. The significance of molecular techniques in the diagnosis of tumours was also shown.

Słowa kluczowe

PL

nowotwory; onkogeneza; transformacja nowotworowa; aspekty molekularne; geny; hormony; mutacje; czasteczki adhezyjne; macierz zewnatrzkomorkowa

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2009
• Tom: 65
• Numer: 05
• Opis fizyczny: s.291-295,rys.,bibliogr.

Twórcy

autor

Madej J A

• Uniwersytet Przyrodniczy we Wroclawiu, ul.Norwida 31, 50-375 Wroclaw

Bibliografia

• 1. Asgeirsson L. S., Jonasson J. C., Tryggvadottir L.: Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur. J. Cancer 2000, 36, 1098-1106.
• 2. Bartolo C., Viswanatha D. S.: Molecular diagnosis in pediatric acute leukemia. Clin. Lab. Med. 2000, 20, 139-145.
• 3. Bertram J. S.: The molecular biology of cancer. Mol. Aspects Med. 2001, 21, 167-173.
• 4. Brown T. A.: Genomes. Wiley - Liss, New York 1999.
• 5. Brzozowski A. K., Pile A. C., Dauter Z.: Molecular basis of agonism and antagonism in the estrogen receptor. Nature 1997, 389, 753-758.
• 6. Chung-Faye G. A., Kerr D. J., Young L. S., Searke P. F.: Gene therapy strategies for colon cancer. Mol. Med. Today 2000, 6, 82-87.
• 7. Clemons M., Goss P.: Estrogen and the risk of breast cancer. N. Engl. J. Med. 2001, 344, 276-281.
• 8. Eichhorst S. T., Krammer P. H.: Derangement of apoptosis in cancer. Lancet 2001, 358, 345-355.
• 9. Epstein R. J.: Biologia molekularna człowieka. Czekaj, Lublin 2005.
• 10. Gustafsson J. A.: New insight in estrogen receptor (ER) research - the ER receptor. Eur. J. Cancer 2000, 36 (suppl), 16-21.
• 11. Haber D.: Roads levding to breast cancer. N. Engl. J. Med. 2000, 343, 1566-1570.
• 12. Hanahan D., Weinberg R. A.: The hallmarks of cancer. Cell 2000, 100, 57-62.
• 13. Little J. B.: Radiation carcinogenesis. Carcinogenesis 2000, 21, 397-404.
• 14. Matos A. J., Lopes C., Carvalheira J., Santos M., Rutteman G. R., Gartner E. F.: E-cadherin expression in canine malignant mammary tumours: relationship to rother clinico-pathological variables. J. Comp. Pathol. 2006, 134, 182-189.
• 15. MSD Mannual (podręcznik diagnostyki i terapii). Berkow R. (red.): Urban&Partner, Wrocław 1955.
• 16. Muntoni A., Reddel R. R.: The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 2005, 2, 191-196.
• 17. Murphy P. M.: Chemokines and the molecular basis of metastasis. N. Engl. J. Med. 2001, 345, 833-839.
• 18. Nakopovlou L., Giaannopoulou J., Stefanaki K.: Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinoma is correled with adverse prognosis. J. Pathol. 2002, 197, 307-313.
• 19. Pellikainen M. J., Pekola T. T., Ropponen K. M.: p21 WAF 1 expression in invasive breast cancer and its associated with p53, AP-2, cell proliferation, and prognosis. J. Clin. Pathol. 2003, 56, 214-220.
• 20. Robbins: Patologia. Elsevier, Urban i Partner, Wrocław 2007.
• 21. Rumsby G., Farrow S. M.: Molecular Endocrinology: Genetic Analysis of Hormones and their Receptors. Academic Press, New York 1999.
• 22. Siedlecki J. A.: Zastosowanie diagnostyki genetycznej w chorobach nowotworowych. Post. Biol. Kom. Supl. 2000, 15, 27-37.
• 23. Umckita Y., Ohi Y., Sagara Y.: Overexpression of cyklin D1 predicts for poor prognosis in estrogen receptor - negative breast cancer patients. Inst. J. Cancer 2005, 19, 574-587.
• 24. Webb C. P., van de Woude G. F.: Genes that regulate metastases and angiogenesis. J. Neurooncol. 2000, 50, 71-78.